Piribo: New publication announcement, Recognizing Unmet Needs in Imaging Biomarker Adoption

This news flash covers analyst views developed during the second IBM Imaging Biomarker Summit (IBS). Interest in imaging biomarkers and momentum from the first IBS meeting, held in December 2005, has clearly increased, as demonstrated by higher attendance (144 participants, up from 90), greater participation by key decision makers, and the shift from introductory presentations to cutting-edge talks that introduced or led to specific discussions of unmet needs and opportunities in the industry. This NewsFlash identifies some of the unmet needs discussed that are expected to provide opportunities for consensus building and collaboration in the near term. With direct access to FDA leadership (Dr. Andrew von Eschenbach and Dr. George Mills from the FDA), the three major imaging vendors, major pharma and biotech, and a number of other key stakeholders, the meeting was an ideal opportunity to accelerate progress in the adoption of imaging biomarkers in drug development.

Contents
News Update
Our View
Learn More

“Recognizing Unmet Needs in Imaging Biomarker Adoption” is available from Piribo. For more information go to: http://www.piribo.com/publications/technology/recognizing_unmet_needs_imaging_biomarker_adoption.html

Piribo Product ID: IDC063

About Piribo.
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.